Our latest news

We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.

Read our latest news to find out more about how we are helping to improve the understanding of liver disease.

Press release | NASH-FX trial shows excellent reproducibility of cT1 as a non-invasive biomarker of liver health Posted: September 10, 2018

LiverMultiScan receives regulatory clearance for clinical use in Australia Posted: August 14, 2018

LiverMultiScan

[Press Release] Large population imaging study reveals utility of LiverMultiScan’s corrected T1 measure as potential biomarker for liver health in metabolic diseases Posted: July 27, 2018

Liver Disease Biomarker liverhealth NAFLD NASH ClinicalTrials

New paediatric study into LiverMultiScan now recruiting healthy volunteers Posted: July 16, 2018

LiverMultiScan

New paper released from the University of Nottingham on quantitative T1 mapping in liver disease Posted: July 10, 2018

Biomarker T1

Good diagnostic accuracy with non-invasive Multiparametric MRI across a range of liver disease severity Posted: July 10, 2018

Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models Posted: July 3, 2018

Liver Disease NAFLD NASH LiverMultiScan

BBC presents LiverMultiScan on the ‘The Big Crash Diet’ Posted: May 30, 2018

LiverMultiScan NAFLD NASH Liver Disease BBC

Analysis of Biobank data shows 1 in 8 adults may have NASH Posted: April 15, 2018

1
2
3
4
5
6
7
8
9
10